Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.32
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 1.18 (35.542%)
Open: 3.50
High: 0.00
Low: 0.00
Prev. Close: 3.50
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome Appoints Geoffrey Ellis As Finance Director, Loss Widens

Tue, 30th Sep 2014 09:41

LONDON (Alliance News) - Proteome Sciences PLC said Tuesday that has appointed Geoffrey Ellis as Finance Director, and posted a slightly widened pretax loss for the half-year to the end of June.

Ellis previously acted as chief financial officer of The Walt Disney Co's Network of Disney Channels in Europe, the Middle East and Africa, and managing director Disney Channel Scandinavia, Middle East and Emerging Markets.

Ellis succeeds James Malthouse, who is retiring after 20 years with the company.

Proteome posted a pretax loss of GBP2.1 million, widened from a loss of GBP1.9 million a year before, as revenue declined to GBP784,276 from GBP885,475, and administrative expenses rose slightly to GBP2.5 million from GBP2.3 million.

The company said following the growth in licensing, services and sales of its Tandem Mass Tag reagents in 2013, its core technologies had continued to strengthen in the first-half of 2014. Some contracts it was expecting were delayed, however, and the company said because of their size it is difficult to predict when they will come through.

Proteome said that whilst it is "difficult to be precise" over the timing of these revenue contributions, the scale and number of contracts in its order book is "growing steady and that performance is expected to continue in 2015."

Sales of Tandem Mass Tag reagent's rose 98% compared to the previous year. Proteome expects to see a more significant contribution from the products in the second-half, as well as continued improvement in its revenues from licences, sales and services.

Last Friday the company announced "excellent" results from in vitro toxicity tests for its two lead compounds to treat Alzheimer's disease, which it hopes will attract pharmaceutical companies to partner with Proteome on the treatments.

Shares in Proteome are trading down 8.0% at 35.18 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
25 Aug 2023 09:11

Proteome Sciences revenue, earnings dip in firist half

(Sharecast News) - Proteome Sciences released its unaudited financial results for the first six months of the year on Friday, reporting an increase in its proteomics services revenues to £1.01m, from £0.85m a year earlier.

Read more
25 Aug 2023 09:10

Proteome Sciences shares fall as swings to interim loss on costs

(Alliance News) - Proteome Sciences PLC on Friday reported higher costs in the first half of 2023 despite revenue remaining virtually flat, causing a swing to a loss.

Read more
4 Jul 2023 14:12

IN BRIEF: OnTheMarket new CFO Tom Carter starts role

OnTheMarket PLC - Aldershot, Hampshire-based property listing website - Confirms that Tom Carter has started his role as chief financial officer. He is the former CFO of beauty brand business Brand Architekts Group PLC, from 2020 until just before starting his role at OnTheMarket. He was previously CFO at the London-based drug development services provider Proteome Science PLC.

Read more
1 Jun 2023 16:43

IN BRIEF: Proteome Sciences repays GBP824,400 loan in full to Vulpes

Proteome Sciences PLC - London-based drug development services provider - Says it has repaid in full its outstanding loan and associated interest, totalling GBP824,424, to Vulpes Investment Management Private Ltd, as originally announced in July 2018 and amended in March last year.

Read more
17 May 2023 14:45

TRADING UPDATES: Proteome Sciences revenue up; Mpac sees improved 2023

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
12 May 2023 11:07

Proteome Sciences to open new San Diego facility

(Sharecast News) - Proteomics service provider Proteome Sciences announced its plan to expand operations into the United States on Friday, with a new facility to be located in San Diego, California.

Read more
12 May 2023 10:23

Proteome Sciences expanding to US with San Diego facility

(Alliance News) - Drug development services provider Proteome Sciences PLC said it is expanding its proteomics services to the US, opening a facility in San Diego.

Read more
4 Apr 2023 11:44

Proteome Sciences reports solid growth in 2022

(Sharecast News) - Biotechnology company Proteome Sciences reported total revenues of £7.78m in its final results on Tuesday - a significant year-on-year increase from £5.13m.

Read more
4 Apr 2023 10:16

Proteome Sciences full-year revenue rises; profit multiplies

(Alliance News) - Proteome Sciences PLC on Tuesday said revenue was up by half, and profit multiplied in 2022.

Read more
20 Feb 2023 11:33

Proteome FY revenues rise, operating costs increase

(Sharecast News) - Shares in contract proteomics services provider Proteome said on Monday that it now expects full-year operating costs to have risen amid, offsetting revenue growth amid an increased investment in staffing and equipment.

Read more
20 Feb 2023 10:34

AIM WINNERS & LOSERS: Mosman wins sacred site certificate at Amadeus

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Feb 2023 10:24

Proteome Sciences shares surge after strong growth in 2022

(Alliance News) - Proteome Sciences PLC on Monday said it has experienced strong growth in both its services and TMT business, with a strong forward order book secured.

Read more
5 Jan 2023 16:31

Proteome gets milestone payment from Thermo Scientific

(Sharecast News) - Proteome Group announced a milestone payment for sales of 'TMT' and 'TMTpro' on Thursday.

Read more
5 Jan 2023 10:45

IN BRIEF: Proteome Sciences reaches "sales milestone" from contract

Proteome Sciences PLC - drug development services provider - Achieves "cumulative sales milestone" with life sciences company Thermo Fisher Scientific Inc. Says a payment of GBP870,000 has been received by the company and will be recognised in the 2022 financial year. Proteome Sciences has an exclusive licence and distributor agreement with Thermo Scientific.

Read more
18 Aug 2022 09:41

IN BRIEF: Proteome Sciences hires Abdelghani Omari as new CFO

Proteome Sciences PLC - drug development services provider - Says it has hired Abdelghani Omari as its new chief financial officer, effective on September 1. Says he will also become the director of the company. Proteome says Omari will join from speciality pharmaceutical company Paion AG, where he has been the chief financial officer since 2014.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.